Insights into the role of potent thiadiazole based Schiff base derivatives in targeting type-II diabetes: A combine in-vitro and in-silico approaches

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis et al. · The Lancet · 2002 · 2.5K citations

Medicine, Pharmacotherapy, Preventive Medicine +14

Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies

Mohammad Asgari, Maryam Mohammadi‐Khanaposhtani, Mitra Kiani et al. · Bioorganic Chemistry · 2019 · 114 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Synthesis and study of the α-amylase inhibitory potential of thiadiazole quinoline derivatives

Muhammad Taha, Muhammad Tariq Javid, Syahrul Imran et al. · Bioorganic Chemistry · 2017 · 107 citations

Life Sciences, Medicinal Chemistry, Pharmacology +14

Synthesis, in vitro bio-evaluation, and molecular docking study of thiosemicarbazone-based isatin/bis-Schiff base hybrid analogues as effective cholinesterase inhibitors

Shoaib Khan, Hayat Ullah, Rafaqat Hussain et al. · Journal of Molecular Structure · 2023 · 94 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis, in vitro α-amylase, α-glucosidase activities and molecular docking study of new benzimidazole bearing thiazolidinone derivatives

Shoaib Khan, Hayat Ullah, Fazal Rahim et al. · Journal of Molecular Structure · 2022 · 78 citations

Pharmacy, Biochemistry, Medicinal Chemistry +15